These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 18685261)

  • 21. [Infliximab. Role in the treatment of psoriasis].
    Mössner R; Reich K
    Hautarzt; 2005 Sep; 56(9):831-2, 834-8. PubMed ID: 16133635
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Personal experience with the use of infliximab].
    Carretero G
    Actas Dermosifiliogr; 2008 Jul; 99 Suppl 4():36-42. PubMed ID: 19080990
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A series of critically challenging case scenarios in moderate to severe psoriasis: a Delphi consensus approach.
    Strober B; Berger E; Cather J; Cohen D; Crowley JJ; Gordon KB; Gottlieb A; Horn EJ; Kavanaugh AF; Korman NJ; Krueger GG; Leonardi CL; Menter A; Schwartzman S; Sobell JM; Young M
    J Am Acad Dermatol; 2009 Jul; 61(1 Suppl 1):S1-S46. PubMed ID: 19527820
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term management of generalized pustular psoriasis with infliximab: case series.
    Routhouska SB; Sheth PB; Korman NJ
    J Cutan Med Surg; 2008; 12(4):184-8. PubMed ID: 18627699
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Therapy of psoriasis-arthritis and psoriasis vulgaris with infliximab].
    Mrowietz U; Barth J; Boehncke WH; Reich K; Rosenbach T; Streit V; Wozel G
    J Dtsch Dermatol Ges; 2006 May; 4(5):444-7. PubMed ID: 16686615
    [No Abstract]   [Full Text] [Related]  

  • 26. From conventional to cutting edge: the new era of biologics in treatment of psoriasis.
    Tzu J; Kerdel F
    Dermatol Ther; 2008; 21(2):131-41. PubMed ID: 18394087
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expert report on psoriasis: Spanish dermatologists' opinions on the use of biologic agents to manage moderate to severe psoriasis in adults.
    Puig L; de la Cueva P; Linares M; Suarez J; Velasco M; Vidal D; Zulaica A; García-Calvo C
    Actas Dermosifiliogr; 2013 Jun; 104(5):400-8. PubMed ID: 23669590
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Treatment of scalp psoriasis: review of the evidence and Delphi consensus of the Psoriasis Group of the Spanish Academy of Dermatology and Venereology].
    Puig L; Ribera M; Hernanz JM; Belinchón I; Santos-Juanes J; Linares M; Querol I; Colomé E; Caballé G
    Actas Dermosifiliogr; 2010 Dec; 101(10):827-46. PubMed ID: 21159259
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Life-threatening pustular and erythrodermic psoriasis responding to infliximab.
    Lewis TG; Tuchinda C; Lim HW; Wong HK
    J Drugs Dermatol; 2006 Jun; 5(6):546-8. PubMed ID: 16774108
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improving clinical trial design in psoriasis: Perspectives from the global dermatology community.
    van de Kerkhof P; Barker J; Griffiths CE; Menter A; Leonardi C; Young M; Kemeny L; Pincelli C; Bachelez H; Katsambas A; Ståhle M; Horn EJ; Sterry W;
    J Dermatolog Treat; 2011 Aug; 22(4):187-93. PubMed ID: 20887207
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Infliximab associated new-onset psoriasis.
    Adams DR; Buckel T; Sceppa JA
    J Drugs Dermatol; 2006 Feb; 5(2):178-9. PubMed ID: 16485887
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Delphi process in dental research.
    Cramer CK; Klasser GD; Epstein JB; Sheps SB
    J Evid Based Dent Pract; 2008 Dec; 8(4):211-20. PubMed ID: 19027655
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Infliximab combined with methotrexate as long-term treatment for erythrodermic psoriasis.
    Heikkilä H; Ranki A; Cajanus S; Karvonen SL
    Arch Dermatol; 2005 Dec; 141(12):1607-10. PubMed ID: 16365275
    [No Abstract]   [Full Text] [Related]  

  • 34. To test or not to test? An evidence-based assessment of the value of screening and monitoring tests when using systemic biologic agents to treat psoriasis.
    Huang W; Cordoro KM; Taylor SL; Feldman SR
    J Am Acad Dermatol; 2008 Jun; 58(6):970-7. PubMed ID: 18384909
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of intertriginous psoriasis: from the Medical Board of the National Psoriasis Foundation.
    Kalb RE; Bagel J; Korman NJ; Lebwohl MG; Young M; Horn EJ; Van Voorhees AS;
    J Am Acad Dermatol; 2009 Jan; 60(1):120-4. PubMed ID: 19103363
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term efficacy of biologics in the treatment of psoriasis: what do we really know?
    Alwawi EA; Krulig E; Gordon KB
    Dermatol Ther; 2009; 22(5):431-40. PubMed ID: 19845720
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sequential therapy in plaque psoriasis using the " Hit and Run " approach: infliximab followed by efalizumab.
    Penz S; Pelletier F; Riou-Gotta MO; Puzenat E; Levang J; Mermet I; Humbert P; Aubin F
    Int J Dermatol; 2012 Feb; 51(2):236-7. PubMed ID: 22250639
    [No Abstract]   [Full Text] [Related]  

  • 38. Adverse drug events in infliximab-treated patients compared with the general and psoriasis populations.
    Menter A; Reich K; Gottlieb AB; Bala M; Li S; Hsu MC; Guzzo C; Diels J; Gelfand JM
    J Drugs Dermatol; 2008 Dec; 7(12):1137-46. PubMed ID: 19137767
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term control of recalcitrant psoriasis with combination infliximab and methotrexate.
    Warren RB; Brown BC; Carmichael AJ; Griffiths CE
    Clin Exp Dermatol; 2009 Apr; 34(3):415-6. PubMed ID: 19120390
    [No Abstract]   [Full Text] [Related]  

  • 40. Three-year registry data on biological treatment for psoriasis: the influence of patient characteristics on treatment outcome.
    Driessen RJ; Boezeman JB; van de Kerkhof PC; de Jong EM
    Br J Dermatol; 2009 Mar; 160(3):670-5. PubMed ID: 19210502
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.